Publication | Closed Access

Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development

VaccinationSolution ElisaAllergyDrug DiscoveryImmunoengineeringImmunologyImmunochemistryDrug DevelopmentAntibody ScreeningMedicineImmunoassays